Mein Warenkorb

Prolactin R

Prolactin R Molekülinformation

Englischer NameProlactin receptorAnzahl der inverkehr gebrachten Arzneimittel0
Anzahl der klinischen Arzneimittel2Target-AliasPRL-R,PRLR,Prolactin Receptor,Secreted Prolactin Binding Protein,HPRL Receptor,RI-PRLR,HPRLrI,HPRL,MFAB,Receptors, Prolactin
Höchste Forschungs- und EntwicklungsphasePhase 3 Clinical
Englischer NameProlactin receptor
Target-AliasPRL-R,PRLR,Prolactin Receptor,Secreted Prolactin Binding Protein,HPRL Receptor,RI-PRLR,HPRLrI,HPRL,MFAB,Receptors, Prolactin
Anzahl der inverkehr gebrachten Arzneimittel0
Anzahl der klinischen Arzneimittel2
Höchste Forschungs- und EntwicklungsphasePhase 3 Clinical

Prolactin R Produktliste

  • Attribut

    Protein (6)

  • Produktbibliothek

    Online (6)

  • Spezies

    Human (3)Cynomolgus (1)Rat (1)Mouse (1)

  • Etikett

    Fc Tag (1)His Tag (4)His Tag & Avi Tag (1)

  • Marker

    Unconjugated (5)Biotin-labeled (1)

Prolactin R Molekülhintergrund

As a transmembrane receptor, the prolactin receptor (PRL-R) interacts with prolactin. In addition, the PRL-R also binds and is activated by growth hormone (GH) and human placental lactogen (hPL). Preclinical investigations, epidemiological studies and analyses of tissue specimens from patients strongly support the contribution of prolactin receptor (PRLR) signaling to breast and prostate tumorigenesis and cancer progression. Moreover, The PRLR has been found to be essential for lobuloalveolar maturation of the mammary glands during pregnancy, as evidenced by the fact that PRLR knockout mice show severely impaired development of lobuloalveolar structures.

Prolactin R Molekülalias

Prolactin R,PRLR,PRL-R

Klinische Arzneimittelinformation

Englischer NameForschungscodeForschungsphaseFirmaIndikationenKlinische Studie
BAY-1158061BAY-1158061; HMI-115Phase 3 ClinicalBayer AGAlopecia; Endometriosis; Pain
Details
ABS-201ABS-201Phase 2 ClinicalAbsci CorpAlopecia; Skin Diseases
Details
  • Molekülinformation
  • Produktliste
  • Klinische Arzneimittelinformation
Kontaktieren Sie uns